The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry
company with leading market positions in Titanium Technologies,
Thermal & Specialized Solutions, and Advanced Performance
Materials, today announced the appointment of Denise Dignam,
current Interim Chief Executive Officer, to the positions of
President and Chief Executive Officer and a member of the Board of
Directors, effective immediately.
Ms. Dignam joined Chemours in 2015. She brings over 35 years of
experience in the chemical industry where she has held senior roles
in business and operations, sales and marketing, commercialization,
and supply chain. She had served as Interim Chief Executive Officer
since February 2024, and prior to that held the positions of
President, Titanium Technologies (TT) segment, and President,
Advanced Performance Materials (APM) segment---two businesses that
represent over 68% of Chemours’ net sales in 2023. As President of
Titanium Technologies, Ms. Dignam stood up the TT Transformation
Plan, delivered significant operational savings in 2023, refocused
the portfolio to deliver more customer value, and developed process
improvements for better resource utilization across the
manufacturing circuit. During her tenure on Advanced Performance
Materials, she reshaped the portfolio to focus resources on secular
growth opportunities in Clean Energy and Advanced Electronics. To
further accelerate growth, she drove strategic partnerships and
initiatives across the globe, and improved the overall cost
structure of the business, laying the foundation for further cost
optimization.
Commenting on her appointment, Ms. Dignam said, “I am excited
and honored to take on the role of President and CEO. Chemours is
defined by its leading chemistries, the customer applications that
our chemistries enable, our manufacturing capabilities, and as
importantly, our people and core values. Looking ahead I will be
focused on strengthening our portfolio with high-value and emerging
growth opportunities, and ensuring we are operating as efficiently,
effectively, and safely as possible. I am committed to continuing
to lead with transparency as we do the hard work required to keep
building our businesses for today and into the future. I want to
thank our Chemours employees around the world, who are the
cornerstone of our success, and our customers and partners for
their continued support.”
Dawn Farrell, Chair of the Board of Chemours, added, “Denise has
the full support of the Board, and we are pleased to have an
experienced and capable executive who is so highly regarded inside
and outside Chemours for her track record leading the APM and TT
business segments. Denise is a high-caliber leader who has the
experience and capability to build value for shareholders while
upholding our core values and serving our valued customers.”
Additional Leadership Changes
Matthew S. Abbott, Interim Chief Financial Officer (CFO), will
continue in his role while we commence a comprehensive search for a
permanent CFO.
“Matt is an incredible partner,” said Ms. Dignam. “His tireless
efforts and leadership have been integral to Chemours’ progress to
this point and will continue to be critical as we navigate the road
ahead of us. Matt has made it clear that he is committed to leading
the Finance organization, building a strong controls environment,
and ensuring the delivery of our financial reporting and
disclosures, while we conduct our search for a permanent CFO to
further enhance our capital structure and achieve shareholder
value.”
Diane Iuliano Picho, Vice President of Human Resources and Chief
of Staff, Titanium Technologies, will step in as Interim President,
Titanium Technologies while we conduct a comprehensive search for a
permanent segment President. Diane brings to the role demonstrated
business acumen over a 40-year career that includes experiences in
R&D, operations, HR, sales, marketing, and commercial
leadership. Previously, Diane was the Vice President of Commercial
Operations for the Advanced Performance Materials segment where she
led product management, supply chain and demand planning, and
competitive intelligence. Before Chemours, Diane held business
roles of increasing responsibility at E.I. du Pont de Nemours,
which she joined in 1983. During that time, as Global Business
Manager of Refrigerants, she led the product development, IP
strategy, commercialization, and launch of the company’s Opteon™
low global warming potential refrigerant offering. She received her
Master of Business Administration from Widener University and her
Bachelor of Science in Mechanical Engineering from Villanova
University.
About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in Titanium
Technologies, Thermal & Specialized Solutions, and Advanced
Performance Materials providing its customers with solutions in a
wide range of industries with market-defining products, application
expertise and chemistry-based innovations. We deliver customized
solutions with a wide range of industrial and specialty chemicals
products for markets, including coatings, plastics, refrigeration
and air conditioning, transportation, semiconductor and consumer
electronics, general industrial, and oil and gas. Our flagship
products are sold under prominent brands such as Ti-Pure™, Opteon™,
Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The company has
approximately 6,200 employees and 28 manufacturing sites serving
approximately 2,700 customers in approximately 110 countries.
Chemours is headquartered in Wilmington, Delaware and is listed on
the NYSE under the symbol CC.
For more information, we invite you to visit chemours.com or
follow us on X (formerly Twitter) @Chemours or on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements, within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which involve
risks and uncertainties. Forward-looking statements provide current
expectations of future events based on certain assumptions and
include any statement that does not directly relate to a historical
or current fact. The words "believe," "expect," "will,"
"anticipate," "plan," "estimate," "target," "project" and similar
expressions, among others, generally identify "forward-looking
statements," which speak only as of the date such statements were
made. These forward-looking statements may address, among other
things, the focus on strengthening Chemours’ portfolio with
high-value and emerging growth opportunities, and ensuring Chemours
is operating efficiently, effectively, and safely as possible, all
of which are subject to substantial risks and uncertainties that
could cause actual results to differ materially from those
expressed or implied by such statements. Forward-looking statements
are based on certain assumptions and expectations of future events
that may not be accurate or realized, such as full year guidance
relying on models based upon management assumptions regarding
future events that are inherently uncertain. These statements are
not guarantees of future performance. Forward-looking statements
also involve risks and uncertainties that are beyond Chemours'
control. Matters outside our control, including general economic
conditions, geopolitical conditions and global health events, have
affected or may affect our business and operations and may or may
continue to hinder our ability to provide goods and services to
customers, cause disruptions in our supply chains such as through
strikes, labor disruptions or other events, adversely affect our
business partners, significantly reduce the demand for our
products, adversely affect the health and welfare of our personnel
or cause other unpredictable events. Additionally, there may be
other risks and uncertainties that Chemours is unable to identify
at this time or that Chemours does not currently expect to have a
material impact on its business. Factors that could cause or
contribute to these differences include the risks, uncertainties
and other factors discussed in our filings with the U.S. Securities
and Exchange Commission, including in our Annual Report on Form
10-K for the year ended December 31, 2022 and our Quarterly Report
on Form 10-Q for the quarter ended September 30, 2023. Chemours
assumes no obligation to revise or update any forward-looking
statement for any reason, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240322251228/en/
INVESTORS Brandon Ontjes VP, Financial Planning &
Analysis, and Investor Relations +1.302.773.3300
investor@chemours.com Kurt Bonner Manager, Investor Relations
+1.302.773.0026 investor@chemours.com NEWS MEDIA Cassie
Olszewski Corporate Media & Brand Reputation Leader
+1.302.219.7140 media@chemours.com
Chemours (NYSE:CC)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Chemours (NYSE:CC)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024